HELX

Franklin Genomic Advancements ETF

$43.60

-1.08%
CategoryHealthcare
Q-Score28/ 100
Net Assets$36.2M
P/E52.08
Dividend Yield0.32%
52-Week Range—
Expense Ratio0.50%
1Y Return+28.9%
Beta0.96
AI summary

Price & performance

1M+0.0%
3M+14.0%
YTD+21.5%
1Y+28.9%
52-week range—
Beta0.96
Full chart and returns against a benchmark

Q-Score

28/ 100

Quality against peers; 50 is the peer median.

Growth59
Risk31
Performance44
Valuation6
Profitability40
Leverage54
Sentiment36
Every score and metric

News sentiment

Open News & Signals

Top holdings

Every holding and the look-through

Fund facts

Expense ratio0.50%
Net assets$36.2M
1-year return+28.9%
Top-10 coverage53.1%
Dividend yield0.32%
Concentration and breadth